Crossveinless-2 (CV-2) is a crucial extracellular regulator within the bone morphogenetic protein (BMP) signaling pathway, which is vital for embryonic development and tissue regeneration. As a member of the Chordin family, CV-2 acts by binding to BMP ligands, thereby modulating their activity and availability to interact with their respective receptors. This regulatory mechanism ensures a fine-tuned balance between BMP signaling propagation and inhibition, which is essential for proper spatial and temporal patterning during development. The importance of CV-2 extends beyond embryogenesis, as it plays a significant role in maintaining tissue homeostasis in adults. It achieves this by influencing cellular processes such as differentiation, proliferation, and apoptosis, which are critical for tissue repair and regeneration. The modulation of BMP signaling by CV-2 is particularly important in the context of skeletal development and repair, where it contributes to the regulation of osteoblast and chondrocyte differentiation, highlighting its integral role in bone and cartilage formation.
The activation of CV-2 and its subsequent modulation of BMP signaling is contingent upon a complex interplay of molecular interactions and modifications. CV-2 is secreted into the extracellular matrix where it can bind directly to BMP ligands, effectively sequestering them from their receptors and preventing excessive BMP signaling. This binding is highly specific and involves a conserved domain within CV-2 that recognizes particular BMPs, ensuring that only targeted signaling pathways are modulated. The regulation of CV-2 activity itself is subject to various post-translational modifications and interactions with other extracellular proteins, which can enhance or inhibit its ability to bind BMPs. For instance, the formation of complexes between CV-2 and other BMP-binding proteins can significantly alter the BMP signaling gradient, a mechanism that is crucial for the precise patterning of tissues during development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alizarin | 72-48-0 | sc-214519 sc-214519A | 1.5 g 100 g | $21.00 $51.00 | ||
Alizarin interacts with BMP signaling by binding to BMP receptors, thereby potentially increasing the functional role of BMPER by reducing direct receptor-mediated BMP pathway repression. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate activates peroxisome proliferator-activated receptor alpha (PPARα), which is known to interact with BMP signaling pathways, potentially enhancing BMPER activity through cross-talk between PPARα signaling and BMP pathways. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), which can influence BMP signaling, thereby potentially enhancing the activity of BMPER by promoting energy homeostasis mechanisms that favor BMP pathway functions. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol (Vitamin D3) influences BMP signaling through VDR-mediated pathways, which can indirectly enhance BMPER activity by promoting BMP-dependent bone formation and repair processes. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through retinoic acid receptors, which have been shown to interact with BMP signaling, potentially enhancing the activity of BMPER by affecting gene expression patterns that favor BMP pathway activation. | ||||||